Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Aug;18(2):135–144. doi: 10.1111/j.1365-2125.1984.tb02445.x

Comparison of the effects of ranitidine, cimetidine and thioridazine on psychomotor functions in healthy volunteers.

N Theofilopoulos, E Szabadi, C M Bradshaw
PMCID: PMC1463513  PMID: 6091708

Abstract

Eight healthy male volunteers participated in four experimental sessions in which they ingested one of the following drugs: ranitidine hydrochloride (150 mg), cimetidine hydrochloride (400 mg), thioridazine hydrochloride (50 mg), placebo (lactose). Drugs were allocated to subjects and sessions in a double-blind fashion, according to a balanced cross-over design. The subjects' mood state and psychomotor performance were assessed 1 and 3 h after drug taking. Mood state was measured using a battery of visual analogue scales, and psychomotor performance using pencil-and-paper tests, critical flicker fusion frequency, wire-maze tracing and tapping. Ranitidine and cimetidine had no significant effect on subjectively rated alertness, whereas thioridazine caused a significant decrease in alertness. Ranitidine and cimetidine had no significant effect on performance on the pencil-and-paper tests (digit cancellation, digit symbol substitution, symbol copying), whereas thioridazine caused a significant decrement on these tests. Ranitidine and cimetidine had no significant effect on critical flicker fusion frequency, wire-maze tracing, and tapping rate. Thioridazine caused a significant impairment of psychomotor performance as evidenced by all the instrumental tests. It is concluded that, in contrast to thioridazine and similarly to cimetidine, ranitidine has little effect on subjectively rated alertness and psychomotor performance in healthy volunteers.

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken R. C. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969 Oct;62(10):989–993. doi: 10.1177/003591576906201005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bories P., Michel H., Duclos B., Beraud J. J., Mirouze J. Use of ranitidine, without mental confusion, in patients with renal failure. Lancet. 1980 Oct 4;2(8197):755–755. doi: 10.1016/s0140-6736(80)91983-2. [DOI] [PubMed] [Google Scholar]
  3. Burland W. L., Duncan W. A., Hesselbo T., Mills J. G., Sharpe P. C., Haggie S. J., Wyllie J. H. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br J Clin Pharmacol. 1975 Dec;2(6):481–486. doi: 10.1111/j.1365-2125.1975.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daly M. J., Humphray J. M., Stables R. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Br J Pharmacol. 1981 Jan;72(1):49–54. doi: 10.1111/j.1476-5381.1981.tb09103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delaney J. C., Ravey M. Cimetidine and mental confusion. Lancet. 1977 Sep 3;2(8036):512–512. doi: 10.1016/s0140-6736(77)91643-9. [DOI] [PubMed] [Google Scholar]
  6. Flind A. C., Rowley-Jones D. Mental confusion and cimetidine. Lancet. 1979 Feb 17;1(8112):379–379. doi: 10.1016/s0140-6736(79)92915-5. [DOI] [PubMed] [Google Scholar]
  7. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. doi: 10.1111/j.1365-2125.1980.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KORNETSKY C., VATES T. S., KESSLER E. K. A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man. J Pharmacol Exp Ther. 1959 Sep;127:51–54. [PubMed] [Google Scholar]
  9. Kimelblatt B. J., Cerra F. B., Calleri G., Berg M. J., McMillen M. A., Schentag J. J. Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology. 1980 Apr;78(4):791–795. [PubMed] [Google Scholar]
  10. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol. 1978 Jul;6(1):15–24. doi: 10.1111/j.1365-2125.1978.tb01676.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Peden N. R., Saunders J. H., Wormsley K. G. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist. Lancet. 1979 Mar 31;1(8118):690–692. doi: 10.1016/s0140-6736(79)91146-2. [DOI] [PubMed] [Google Scholar]
  12. Schentag J. J., Cerra F. B., Calleri G., DeGlopper E., Rose J. Q., Bernhard H. Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet. 1979 Jan 27;1(8109):177–181. doi: 10.1016/s0140-6736(79)90578-6. [DOI] [PubMed] [Google Scholar]
  13. Sewing K. F., Billian A., Malchow H. Comparative study with ranitidine and cimetidine on gastric secretion. Scand J Gastroenterol Suppl. 1981 Jun;69:45–49. [PubMed] [Google Scholar]
  14. Smith J. M., Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacologia. 1976 May 28;47(2):175–182. doi: 10.1007/BF00735818. [DOI] [PubMed] [Google Scholar]
  15. Szabadi E., Bradshaw C. M., Gaszner P. The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers. Psychopharmacology (Berl) 1980;68(2):125–134. doi: 10.1007/BF00432129. [DOI] [PubMed] [Google Scholar]
  16. Thompson J., Lilly J. Cimetidine-induced cerebral toxicity in children. Lancet. 1979 Mar 31;1(8118):725–725. [PubMed] [Google Scholar]
  17. Walt R. P., LaBrooy S. J., Avgerinos A., Oehr T., Riley A., Misiewicz J. J. Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones. Scand J Gastroenterol Suppl. 1981 Jun;69:19–25. [PubMed] [Google Scholar]
  18. Wood C. A., Isaacson M. I., Hibbs M. S. Cimetidine and mental confusion. JAMA. 1978 Jun 16;239(24):2550–2551. doi: 10.1001/jama.1978.03280510034011. [DOI] [PubMed] [Google Scholar]
  19. Woodings E. P., Dixon G. T., Harrison C., Carey P., Richards D. A. Ranitidine--a new H2-receptor antagonist. Gut. 1980 Mar;21(3):187–191. doi: 10.1136/gut.21.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES